NovaBay® Pharmaceuticals, Inc. (NYSE: NBY) announced that, pursuant to authorization provided by the Company’s stockholders at the Company’s December 11 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE